Lanean...
Bispecific T cell engagers for cancer immunotherapy
Bispecific T cell engagers are a new class of immunotherapeutic molecules intended for the treatment of cancer. These molecules, termed BiTEs, enhance the patient’s immune response to tumors by retargeting T cells to tumor cells. BiTEs are constructed of two single chain variable fragments (scFv) co...
Gorde:
| Argitaratua izan da: | Immunol Cell Biol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445461/ https://ncbi.nlm.nih.gov/pubmed/25367186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/icb.2014.93 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|